Changes in antigen expression on differentiating HL60 cells treated with dimethylsulphoxide, all-trans retinoic acid, alpha1,25-dihydroxyvitamin D3 or 12-O-tetradecanoyl phorbol-13-acetate.

We describe changes in antigen expression on HL60 cells with differentiation into granulocytes induced by all-trans retinoic acid (ATRA) or dimethylsulphoxide (DMSO), into monocytes by alpha1,25-dihydroxyvitamin D3 (D3), or into macrophages by 12-O-tetradecanoyl phorbol-13-acetate (TPA). Undifferentiated cells expressed CD13, CD14 (at a low level), CD15, CDw17, CD32, CD33, CD49e, CD63, CD64, CDw65, CD71 and CD87 antigens and bound the unclustered mAb D171 and Mo5. Differentiated and undifferentiated cells were negative for CD16, CD34, CD61, CD66abcde, CD68, CD88, CDw90 and CD93. Four panels of markers were identified whose expression changes significantly following differentiation. CD15, CD49e, CD63, CDw65, CD71 and mAb D171 and IGR-2,1A6 for DMSO; CD13, CD15, CDw17, CD49e, CD63, CDw65, CD71, CD87, CDw92 and mAb D171 and IGR-2,1A6 for ATRA; CD14, CD31, CD35, CD71, CD87, CDw92 and mAb D171 and BRIC18 for D3; CDw12, CD13, CD15, CD31, CD35, CD49e, CD71, CD87, CDw92 and mAb D171 for TPA. These will be useful for analyzing the pathways that regulate differentiation, whether the observed changes are consequences of differentiation or more direct effects of the inducers. HL60 cells provide a model for investigating the regulation of these antigens.

[1]  H Zola,et al.  1,25-dihydroxyvitamin D3 inhibits proliferation of human promyelocytic leukaemia (HL60) cells and induces monocyte-macrophage differentiation in HL60 and normal human bone marrow cells. , 1983, Leukemia research.

[2]  C. Bunce,et al.  Treatment of HL60 cells with various combinations of retinoids and 1 alpha,25 dihydroxyvitamin D3 results in differentiation towards neutrophils or monocytes or a failure to differentiate and apoptosis. , 1995, Leukemia.

[3]  S. Collins,et al.  Normal functional characteristics of cultured human promyelocytic leukemia cells (HL-60) after induction of differentiation by dimethylsulfoxide , 1979, The Journal of experimental medicine.

[4]  A. Sartorelli,et al.  Regulation of transferrin receptor in myeloid and monocytic differentiation of HL-60 leukemia cells. , 1989, Cancer research.

[5]  S. Nonoyama,et al.  Induction of CD40 in promyelocytic HL60 cells cultured with retinoic acid and/or various cytokines. , 1995, Journal of biochemistry.

[6]  S. Collins,et al.  Characterization of the continuous, differentiating myeloid cell line (HL-60) from a patient with acute promyelocytic leukemia , 1979 .

[7]  J. Ritz,et al.  Expression of normal monocyte-macrophage differentiation antigens on HL60 promyelocytes undergoing differentiation induced by leukocyte-conditioned medium or phorbol diester. , 1981, Leukemia research.

[8]  R. Stone,et al.  All-trans retinoic acid induces monocyte growth factor receptor (c-fms) gene expression in HL-60 leukemia cells. , 1993, Leukemia.

[9]  F. Lopez,et al.  Monoclonal antibody to transferrin receptor blocks transferrin binding and inhibits human tumor cell growth in vitro. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[10]  S. Collins,et al.  The HL-60 promyelocytic leukemia cell line: proliferation, differentiation, and cellular oncogene expression. , 1987, Blood.

[11]  D. Mason,et al.  Immunohistological patterns of myeloid antigens: tissue distribution of CD13, CD14, CD16, CD31, CD36, CD65, CD66 and CD67 , 1993, British journal of haematology.

[12]  E. Schiavone,et al.  All‐trans retinoic acid promotes a differential regulation of adhesion molecules on acute myeloid leukaemia blast cells , 1994, British journal of haematology.

[13]  A. Deisseroth,et al.  Identification of a population of bipotent stem cells in the HL60 human promyelocytic leukemia cell line. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[14]  S. Collins,et al.  Continuous growth and differentiation of human myeloid leukaemic cells in suspension culture , 1977, Nature.

[15]  Hirofumi Tanaka,et al.  1 alpha,25-dihydroxyvitamin D3 induces differentiation of human promyelocytic leukemia cells (HL-60) into monocyte-macrophages, but not into granulocytes. , 1983, Biochemical and biophysical research communications.

[16]  P. Newburger,et al.  Relationships between the cell cycle and the expression of c-myc and transferrin receptor genes during induced myeloid differentiation. , 1990, Experimental cell research.

[17]  I. Bernstein,et al.  Leukocyte Typing II , 1986, Springer New York.

[18]  P. Allen,et al.  Modulation of CD13 expression during retinoic acid-induced differentiation of HL60 cells. , 1994, Leukemia research.

[19]  C. Damsky,et al.  Human promyelocytic leukemia cells in culture differentiate into macrophage-like cells when treated with a phorbol diester. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[20]  E. Freireich,et al.  HL-60 cell line was derived from a patient with FAB-M2 and not FAB-M3. , 1988, Blood.

[21]  T. Katada,et al.  NAD glycohydrolase specifically induced by retinoic acid in human leukemic HL-60 cells. Identification of the NAD glycohydrolase as leukocyte cell surface antigen CD38. , 1993, The Journal of biological chemistry.

[22]  S. Collins,et al.  Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[23]  F. Farzaneh,et al.  Quantitative multiwell myeloid differentiation assay using dichlorodihydrofluorescein diacetate (H2DCF-DA) or dihydrorhodamine 123 (H2R123). , 1995, Journal of immunological methods.